Casdin Capital, LLC Exact Sciences Corp Transaction History

Casdin Capital, LLC

$1.16 Billion
Q2 2024

A detailed history of Casdin Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Casdin Capital, LLC holds 650,000 shares of EXAS stock, worth $46.8 Million. This represents 2.37% of its overall portfolio holdings.

Number of Shares

650,000

Previous 650,000 -0.0%

Holding current value

$46.8 Million

Previous $27.5 Million -0.0%

% of portfolio

2.37%

Previous 2.38%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $12.9 Million - $17 Million	230,000 Added 54.76%	650,000 $44.9 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $2.33 Million - $2.99 Million	-39,450 Reduced 8.59%	420,000 $31.1 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $2.67 Million - $4.02 Million	-40,550 Reduced 8.11%	459,450 $31.3 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $4.07 Million - $6.18 Million	-65,000 Reduced 11.5%	500,000 $47 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $12.2 Million - $21.4 Million	-402,000 Reduced 41.57%	565,000 $28 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $16.5 Million - $25.5 Million	517,000 Added 114.89%	967,000 $31.4 Million
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $31.3 Million - $67.1 Million	-880,000 Reduced 66.17%	450,000 $17.7 Million
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $40.9 Million - $58.6 Million	-710,000 Reduced 34.8%	1,330,000 $93 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $23.2 Million - $32.2 Million	-320,186 Reduced 13.57%	2,040,000 $159 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $102 Million - $136 Million	875,037 Added 58.92%	2,360,186 $311 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $148 Million - $211 Million	1,485,149 New	1,485,149 $197 Million

Others Institutions Holding EXAS

# of Institutions

624

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account

Casdin Capital, LLC Exact Sciences Corp Transaction History